National Institute on Alcohol Abuse and Alcoholism (NIAAA)
MEETING OF THE INTERAGENCY COORDINATING COMMITTEE ON FETAL ALCOHOL SPECTRUM DISORDERS National Institute on Alcohol Abuse and Alcoholism 5635 Fishers Lane, Terrace Level Conference Center, Rockville, Maryland 20852 Wednesday, April 15, 2015 AGENDA 8:30 A.M. Welcome, Introductions, and Comments Kenneth R. Warren, Ph.D., Deputy Director, NIAAA, NIH; ICCFASD Chairperson 8:40 A.M. Overview of 6th International FASD Conference Peggy Murray, Ph.D...
A pilot study of a smartphone-based intervention found that the mobile app helped people with an alcohol use disorder to reduce their alcohol consumption. The pilot program was supported in part by a grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Patrick Dulin, PhD, an associate professor at the University of Alaska Anchorage, led the study. He...
AUDs often untreated Alcohol use disorder, or AUD, is the medical diagnosis for problem drinking that causes mild to severe distress or harm. A new study supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, reports that nearly one-third of adults in the United States have an AUD at some time...
NIAAA Spectrum is an online Webzine published by the National Institute on Alcohol Abuse and Alcoholism. It features the latest news from the alcohol research field, infographics, and interviews with NIAAA staff and researchers from the field. The latest issue is now available. In this issue... Drinking and the Liver: Seeking Better Treatments for Alcoholic Liver Disease The liver is...
The Research Society on Alcoholism ( RSA ) has selected David Goldman, M.D., of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) to receive the Distinguished Researcher Award. This award recognizes a senior researcher who, through sustained, long-term commitment to conducting alcohol research, has made outstanding scientific contributions to the field. Dr. Goldman is chief of the Laboratory of...
A clinical trial investigating a potential treatment for alcohol use disorder (AUD) was announced by the National Institute on Alcohol Abuse and Alcoholism (NIAAA). The study will assess the safety and efficacy of gabapentin enacarbil (HORIZANT) in extended-release tablets for treating moderate to severe AUD. NIAAA is part of the National Institutes of Health. Gabapentin is already widely prescribed to...
On March 25, 2015, CNN Chief Medical Correspondent and neurosurgeon Dr. Sanjay Gupta (middle) met with NIAAA Director Dr. George Koob (right) in the laboratory of Dr. Lorenzo Leggio (left). Dr. Leggio is chief of the Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, which is run jointly by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute...
Chat with NIAAA experts about the latest in blood alcohol monitoring technology and our $200,000 challenge to design a better wearable alcohol biosensor. # AlcoholBiosensor
At the June 10th meeting of the National Advisory Council on Alcohol Abuse and Alcoholism, a proposal to establish a new Division of Medications Development within the National Institute on Alcohol Abuse and Alcoholism (NIAAA) was announced. For additional details, view the slides at https://www.niaaa.nih.gov/sites/default/files/Reorg_creationMedDevDivCo…